Patents by Inventor Peter Jones
Peter Jones has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12278693Abstract: A method of implementing a stretched single optical communication span includes receiving one or more optical signals from an optical fiber span having high loss; adding a pilot signal to the one or more optical signals, subsequent to the receiving; and amplifying the one or more optical signals and the pilot signal with a pre-amplifier that is an Erbium Doped Fiber Amplifier (EDFA). Advantageously, the stretched single span operates below a Hazard 1M environment. A node in a stretched single optical communication span includes an optical multiplexer connected to an optical fiber span having high and a pilot signal, and configured to output a combination of one or more optical signals from the optical fiber span and the pilot signal; and a pre-amplifier that is an EDFA configured to receive the output of the optical multiplexer and provide amplification of the one or more optical signals and the pilot signal.Type: GrantFiled: December 6, 2022Date of Patent: April 15, 2025Assignee: Ciena CorporationInventors: Kevan Peter Jones, Vipul Bhatnagar, Marco Gaudet, Francois Maurice Rheal Charron
-
Publication number: 20240395234Abstract: Systems and methods for dewatering slurries having relatively high solids content such as earthen slurries are disclosed. In some embodiments, one or more transducer devices configured for acoustic spectroscopy and/or electroacoustic spectroscopy are used to determine a parameter related to the particle size distribution (e.g., specific surfaced area) and/or zeta potential of the slurry.Type: ApplicationFiled: August 1, 2024Publication date: November 28, 2024Inventors: Gregory Anderson, Brandon Storm, Andrew Strobel, Corey Lanoue, Tayte Askelsen, Samuel Edmund Whittome, Ross Peter Jones
-
Publication number: 20240359839Abstract: Methods and apparatus for unitizing groups of individual packages into pallet loads, stabilizing the loads and facilitating general movement of the pallets, including the loading and unloading of pallets into and out of transport vehicles, includes wrapping the loads with stretchable crepe paper, rather than conventional plastic wrap material. Crepe paper can be produced and recycled with less environmental impact than plastic wrap. These methods involve a new use for crepe paper, and a new use for conventional plastic-wrapping equipment.Type: ApplicationFiled: July 9, 2024Publication date: October 31, 2024Inventors: Peter Jones, Dave Dexter, Bernd Firmbach, Chris Killay, James B. Jones
-
Patent number: 12124562Abstract: A method includes configuring one or more permissions for a first page of memory including a first section of a plurality of sections of an executable program code to enable execution of the first section. The method also includes configuring one or more permissions for a second page of the memory including a second section of the executable program code to disable execution of the second section. The method also includes identifying one or more annotations in the executable program code, wherein the one or more annotations indicate one or more allowed transitions and one or more disallowed transitions between the plurality of sections. The method also includes changing, in view of the one or more annotations, the one or more permissions of the second page to enable execution of the second section of the executable program code.Type: GrantFiled: February 14, 2022Date of Patent: October 22, 2024Assignee: Red Hat, Inc.Inventors: Peter Jones, Adam Jackson
-
Publication number: 20240336582Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.Type: ApplicationFiled: June 17, 2024Publication date: October 10, 2024Inventors: Hans Roland LÖNN, Stephen CONNOLLY, Steven SWALLOW, Staffan Po KARLSSON, Carl-Johan AURELL, John Fritiof PONTÉN, Kevin James DOYLE, Amanda Jane VAN DE POËL, Graham Peter JONES, David Wyn WATSON, Jaqueline Anne MACRITCHIE, Nicholas John PALMER
-
Publication number: 20240336614Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: ApplicationFiled: October 16, 2023Publication date: October 10, 2024Inventors: Upul Keerthi BANDARAGE, Cavan McKeon BLIGH, Diane BOUCHER, Michael John BOYD, Michael Aaron BRODNEY, Michael Philip CLARK, Veronique DAMAGNEZ, Lev Tyler Dewey FANNING, Robert Francis FIMOGNARI, Gabrielle Simone FLEMING, Kevin James GAGNON, Pedro Manuel GARCIA BARRANTES, Robert Daniel GIACOMETTI, Simon GIROUX, Ronald Lee GREY, JR., Samantha GUIDO, Amy Beth HALL, Sarah Carol HOOD, Dennis James HURLEY, Mac Arthur JOHNSON, JR., Peter Jones, Sarathy KESAVAN, Mei-Hsiu LAI, Siying LIU, Adam LOOKER, Brad MAXWELL, John Patrick MAXWELL, Ales MEDEK, Philippe Marcel NUHANT, Kirk Alan OVERHOFF, Setu RODAY, Stefanie ROEPER, Steven M. RONKIN, Rupa SAWANT, Yi SHI, Muna SHRESTHA, Marisa SPOSATO, Kathy STAVROPOULOS, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Qing TANG, Stephen THOMSON, Jinwang XU, Mariam ZAKY, Kevin Michael COTTRELL
-
Publication number: 20240293298Abstract: A cosmetic aerosol product comprising a pressurised container holding a base composition and a propellant which is a mixture of a compressed gas and a liquefied gas at a weight ratio of from 0.1: 99.9 to 10: 90; wherein the pressurised container comprises: i). a pressure release valve; ii). a reservoir containing the base composition and the propellant; and iii). a dip tube arranged for the transport of the base composition from the reservoir to the pressure release valve; wherein the base composition comprises a suspension of a particulate solid cosmetic active in a carrier oil, the particulate solid cosmetic active having a concentration of from 5 to 40% by weight in the base composition.Type: ApplicationFiled: February 29, 2024Publication date: September 5, 2024Inventors: James Peter Jones, Louise Ombler McMaster
-
Patent number: 12067962Abstract: Systems and methods for dewatering slurries having relatively high solids content such as earthen slurries are disclosed. In some embodiments, one or more transducer devices configured for acoustic spectroscopy and/or electroacoustic spectroscopy are used to determine a parameter related to the particle size distribution (e.g., specific surfaced area) and/or zeta potential of the slurry.Type: GrantFiled: July 18, 2018Date of Patent: August 20, 2024Assignee: Vermeer Manufacturing CompanyInventors: Gregory Anderson, Brandon Storm, Andrew Strobel, Corey Lanoue, Tayte Askelsen, Samuel Edmund Whittome, Ross Peter Jones
-
Patent number: 12060175Abstract: Methods and apparatus for unitizing groups of individual packages into pallet loads, stabilizing the loads and facilitating general movement of the pallets, including the loading and unloading of pallets into and out of transport vehicles, includes wrapping the loads with stretchable crepe paper, rather than conventional plastic wrap material. Crepe paper can be produced and recycled with less environmental impact than plastic wrap. These methods involve a new use for crepe paper, and a new use for conventional plastic-wrapping equipment.Type: GrantFiled: March 21, 2022Date of Patent: August 13, 2024Assignee: Seaman Paper Company of Massachusetts, Inc.Inventors: Peter Jones, Dave Dexter, Bernd Firmbach, Chris Killay, James B. Jones
-
Patent number: 12054465Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.Type: GrantFiled: December 8, 2023Date of Patent: August 6, 2024Assignee: AstraZeneca ABInventors: Hans Roland Lönn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
-
Publication number: 20240197200Abstract: A device includes a sensor and a control portion. The sensor is securable to a patient to provide a sensor signal. The sensor is to sense changes in acceleration indicative of respiration of the patient. The control portion is to determine a midpoint of each respiratory phase of the patient based on the sensor signal.Type: ApplicationFiled: June 9, 2022Publication date: June 20, 2024Applicant: INSPIRE MEDICAL SYSTEMS, INC.Inventors: Christopher Thorp, David Dieken, Nicholas Nesbitt, John Rondoni, James Manne-Nicholas, Ross Peter Jones, Mark Schatza, Christopher Nicholas Warwick, Jonathan Tudor Stone, Frederico CANAS DE MATOS E OLIVEIRA RIBEIRO
-
Patent number: 12007744Abstract: A plurality of system control devices respectively include network interfaces for communicating with each other via a network. One of the plurality of system control devices functions as a master system control device, and the remaining system control devices function as slave system control devices. The master system control device transmits a control command to the slave system control devices by means of the network interface. The slave system control devices receive the control command by means of the network interfaces and supply an operation command to abatement devices in accordance with the control command. When unable to communicate with the master system control device, the slave system control devices either function as master system control devices or enter stand-alone operation mode.Type: GrantFiled: August 5, 2019Date of Patent: June 11, 2024Assignees: Edwards Japan Limited, Edwards LimitedInventors: Kobayashi Kenichiro, Adrian Fisher, Christopher Peter Jones, Philip Carr
-
Publication number: 20240187123Abstract: A method of implementing a stretched single optical communication span includes receiving one or more optical signals from an optical fiber span having high loss; adding a pilot signal to the one or more optical signals, subsequent to the receiving; and amplifying the one or more optical signals and the pilot signal with a pre-amplifier that is an Erbium Doped Fiber Amplifier (EDFA). Advantageously, the stretched single span operates below a Hazard 1M environment. A node in a stretched single optical communication span includes an optical multiplexer connected to an optical fiber span having high and a pilot signal, and configured to output a combination of one or more optical signals from the optical fiber span and the pilot signal; and a pre-amplifier that is an EDFA configured to receive the output of the optical multiplexer and provide amplification of the one or more optical signals and the pilot signal.Type: ApplicationFiled: December 6, 2022Publication date: June 6, 2024Inventors: Kevan Peter Jones, Vipul Bhatnagar, Marco Gaudet, Francois Maurice Rheal Charron
-
Publication number: 20240132455Abstract: The present disclosure relates to certain (2S)—N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.Type: ApplicationFiled: December 8, 2023Publication date: April 25, 2024Inventors: Hans Roland LÖNN, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof PONTÉN, Kevin James Doyle, Amanda Jane VAN DE POËL, Graham Peter Jones, David Wyn Watson, Jacqueline Anne MACRITCHIE, Nicholas John Palmer
-
Patent number: 11927807Abstract: According to various aspects of the present disclosure, an apparatus is provided. In an aspect, the apparatus includes an optical transceiver having a first port, a second port and an optical switch coupled to the first port and the second port. The optical switch is switchable between a unidirectional port operation mode and a bidirectional port operation mode. When the optical switch is in the unidirectional port operation mode, the first port is configured to send a first optical signal, and the second port configured to receive a second optical signal. When the optical switch is in the bidirectional port operation mode, the first port configured to send the first optical signal and receive the second optical signal, and the second port configured to receive a third optical signal and not send the first signal.Type: GrantFiled: November 29, 2022Date of Patent: March 12, 2024Assignee: Juniper Networks, Inc.Inventors: Kevan Peter Jones, Robert William Keys
-
Patent number: 11884672Abstract: The disclosure provides compounds useful for treating alpha-1 antitrypsin deficiency (AATD), according to formula (I): tautomers thereof, pharmaceutically acceptable salts of the compounds, pharmaceutically acceptable salts of the tautomers, deuterated derivatives of the compounds, deuterated derivatives of the tautomers, and deuterated derivatives of the salts, solid forms of those compounds and processes for making those compounds.Type: GrantFiled: May 13, 2020Date of Patent: January 30, 2024Assignee: Vertex Pharmaceuticals IncorporatedInventors: Upul Keerthi Bandarage, Cavan McKeon Bligh, Diane Boucher, Michael John Boyd, Michael Aaron Brodney, Michael Philip Clark, Veronique Damagnez, Lev Tyler Dewey Fanning, Robert Francis Fimognari, Gabrielle Simone Fleming, Kevin James Gagnon, Pedro Manuel Garcia Barrantes, Robert Daniel Giacometti, Simon Giroux, Ronald Lee Grey, Jr., Samantha Guido, Amy Beth Hall, Sarah Carol Hood, Dennis James Hurley, Mac Arthur Johnson, Jr., Peter Jones, Sarathy Kesavan, Mei-Hsiu Lai, Siying Liu, Adam Looker, Brad Maxwell, John Patrick Maxwell, Ales Medek, Philippe Marcel Nuhant, Kirk Alan Overhoff, Setu Roday, Stefanie Roeper, Steven M. Ronkin, Rupa Sawant, Yi Shi, Muna Shrestha, Marisa Sposato, Kathy Stavropoulos, Rebecca Jane Swett, Timothy Lewis Tapley, Qing Tang, Stephen Thomson, Jinwang Xu, Mariam Zaky, Kevin Michael Cottrell
-
Patent number: 11814359Abstract: The present disclosure relates to certain (2,S)-N-[(1,S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.Type: GrantFiled: September 10, 2022Date of Patent: November 14, 2023Assignee: AstraZeneca ABInventors: Hans Roland Lönn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jacqueline Anne Macritchie, Nicholas John Palmer
-
Publication number: 20230339915Abstract: Novel compounds, compositions, and methods of using and preparing the same, which maybe useful for treating alpha-1 antitrypsin deficiency (AATD).Type: ApplicationFiled: April 2, 2021Publication date: October 26, 2023Inventors: Simon GIROUX, Michael Philip CLARK, Qing TANG, Philippe Marcel NUHANT, Peter JONES, David MESSERSMITH, Upul Keerthi BANDARAGE, Kevin Michael COTTRELL, Michael Aaron BRODNEY, Gabrielle Simone FLEMING, Jian WANG, Jinwang XU, Kevin Brett DANIEL, Michael John BOYD, Mark A. MORRIS, Nathan D. WAAL, Philip Noel COLLIER, Sarathy KESAVAN, Steven M. RONKIN, Hongbo DENG, Diane Marie BOUCHER, Lev T.D. FANNING, Amy B. HALL, Dennis James HURLEY, Mac Arthur JOHNSON, Jr., John Patrick MAXWELL, Rebecca Jane SWETT, Timothy Lewis TAPLEY, Stephen A. THOMSON, Veronique DAMAGNEZ
-
Patent number: 11773069Abstract: The present disclosure relates to certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamide compounds (including pharmaceutically acceptable salts thereof), that inhibit dipeptidyl peptidase 1 (DPP1) activity, to their utility in treating and/or preventing clinical conditions including respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), to their use in therapy, to pharmaceutical compositions containing them and to processes for preparing such compounds.Type: GrantFiled: September 9, 2022Date of Patent: October 3, 2023Assignee: AstraZeneca ABInventors: Hans Roland Lönn, Stephen Connolly, Steven Swallow, Staffan Po Karlsson, Carl-Johan Aurell, John Fritiof Pontén, Kevin James Doyle, Amanda Jane Van De Poël, Graham Peter Jones, David Wyn Watson, Jaqueline Anne Macritchie, Nicholas John Palmer
-
Patent number: D1017465Type: GrantFiled: September 20, 2021Date of Patent: March 12, 2024Assignee: Ford Global Technologies, LLCInventors: Max Wolff, Maurizio Tocco, David Dewitt, Andrew Wolton, Nonthawat Kongsari, Siddhartha Kazami, Rohan Satyamurthy, Emily Lai, Luana Teixeira, Peter Jones
